Expanded building blocks Iris Biotech offers a broad portfolio of standard reagents, unusual building blocks, protected amino acids, coupling reagents, linkers, resins, and thousands of other building blocks and resins, presenting cross-selling opportunities to peptide modification and drug discovery teams seeking diverse materials in one supplier.

PROTAC and Linkerology The company is expanding into PROTAC building blocks and advanced linkers through its Linkerology division, indicating potential sales to clients pursuing targeted protein degradation and complex conjugation strategies, including defined stability or predetermined breaking points.

Polymer and PEG Expertise Iris Biotech maintains a world-class portfolio of PEGylation reagents and novel, biodegradable polymers, enabling pitches to biotech and pharma customers focusing on drug delivery, bioconjugation, and improved pharmacokinetics.

Clinical and research partnerships Recent activities such as participation in nanomaterials for tumor immunotherapy events and ongoing research collaborations suggest opportunities to partner on projects at the interface of materials science, immunotherapy, and peptide-based therapeutics.

Rapid product innovation Frequent product launches (CliCr click chemistry, Smoc amino acids, guanidino-proline constrained arginine analogs) demonstrate a fast-moving product roadmap, enabling sales teams to position Iris as a source of cutting-edge building blocks and novel reagents for advanced peptide science.